Barclays Maintains an 'Equalweight' on Tempur-Pedic (TPX); Raising Numbers on Q2 Results
Tweet Send to a Friend
Barclays maintains an 'Equalweight' on Tempur-Pedic (NYSE: TPX) price target raised from $65 to $75.
Barclays analyst says, "Tempur-Pedic reported ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays analyst says, "Tempur-Pedic reported ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
